The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I/II trial assessing hydroxychloroquine and itraconazole in women with advanced platinum-resistant epithelial ovarian cancer (EOC) (HYDRA-01).
 
Ainhoa Madariaga
No Relationships to Disclose
 
Stefano Marastoni
No Relationships to Disclose
 
Ilaria Colombo
Employment - Medtronic (I)
Stock and Other Ownership Interests - Medtronic (I)
Travel, Accommodations, Expenses - Tesaro
 
Victoria Mandilaras
No Relationships to Disclose
 
Michael Cabanero
No Relationships to Disclose
 
Jeffrey Bruce
Stock and Other Ownership Interests - Bowhead Health
Consulting or Advisory Role - Bowhead Health
 
Swati Garg
No Relationships to Disclose
 
Lisa Wang
No Relationships to Disclose
 
Sarbjot Gill
No Relationships to Disclose
 
Neesha C. Dhani
Honoraria - AstraZeneca; Celgene
Consulting or Advisory Role - AstraZeneca; Celgene; Shire
Research Funding - AstraZeneca (Inst); Celgene; Celgene (Inst); Halozyme (Inst)
Travel, Accommodations, Expenses - Celgene
 
Valerie Bowering
Honoraria - AstraZeneca
Consulting or Advisory Role - AstraZeneca
 
Xuan Li
No Relationships to Disclose
 
Amit M. Oza
Honoraria - Intas
Consulting or Advisory Role - Immunogen; Merck KGaA
Research Funding - AstraZeneca (Inst); Immunovaccine (Inst)
Travel, Accommodations, Expenses - AstraZeneca
Other Relationship - AstraZeneca; Clovis Oncology; Clovis Oncology; Merck; Tesaro
 
Anthony M. Joshua
Consulting or Advisory Role - AstraZeneca (Inst); Ipsen (Inst); IQvia (Inst); Janssen Oncology (Inst); Neoleukin Therapeutics (Inst); Noxopharm (Inst); Pfizer (Inst); Sanofi (Inst)
Research Funding - AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Corvus Pharmaceuticals (Inst); Janssen Oncology (Inst); Lilly (Inst); Lilly (Inst); Macrogenics (Inst); Mayne Pharma (Inst); Merck Sharp & Dohme (Inst); Pfizer (Inst); Roche/Genentech (Inst)
 
Stephanie Lheureux
Honoraria - AstraZeneca
Consulting or Advisory Role - AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; Merck; Roche/Genentech
Research Funding - AstraZeneca (Inst); Merck (Inst); Regeneron (Inst); Roche/Genentech (Inst); Tesaro (Inst)